<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="165526">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00943046</url>
  </required_header>
  <id_info>
    <org_study_id>43-1</org_study_id>
    <nct_id>NCT00943046</nct_id>
  </id_info>
  <brief_title>Master Study for the Investigation of Safety and Efficacy of the SIELLO Pacemaker Leads</brief_title>
  <official_title>Master Study of the SIELLO Pacemaker Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <brief_summary>
    <textblock>
      The objective of this study is to prove the safety and efficacy of the SIELLO pacemaker
      leads.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication free rate of all SIELLO leads</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventricular threshold of SIELLO T (passive fixation)</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Atrial threshold of SIELLO S (active fixation)</measure>
    <time_frame>3 month follow-up visits</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pacemaker Indication</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker lead</intervention_name>
    <description>Implantation of the SIELLO pacemaker leads</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet the indications for pacemaker therapy

          -  Understand the nature of the procedure

          -  Give informed consent

          -  Able to complete all testing required by the clinical protocol

          -  Available for follow-up visits on a regular basis at the investigational site

        Exclusion Criteria:

          -  Meet none of the pacemaker indications

          -  Meet one or more of the contraindications

          -  Have a life expectancy of less than six months

          -  Cardiac surgery in the next six months -Enrolled in another cardiac clinical
             investigation- Have other medical devices that may interact with the implanted
             pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anselm Schaumann, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>n.k.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anselm Schaumann, Dr.</last_name>
    <phone>+49-40-1818818365</phone>
    <email>a.schaumann@asklepios.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Hamburg Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anselm Schaumann, Dr.</last_name>
      <email>a.schaumann@asklepios.com</email>
    </contact>
    <investigator>
      <last_name>Anselm Schaumann, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <lastchanged_date>February 12, 2010</lastchanged_date>
  <firstreceived_date>July 14, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Mrs. Gundula Herrmann</name_title>
    <organization>Biotronik GmbH &amp; Co. KG</organization>
  </responsible_party>
  <keyword>leads</keyword>
  <keyword>pacemaker</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
